PolyCore Therapeutics Competitors and Similar CompaniesClear all
PolyCore Therapeutics's competitors and similar companies include Sosei Heptares and Travere Therapeutics.
 PolyCore Therapeutics PolyCore Therapeutics is a biopharmaceutical company developing treatments for dyskinesia and cognitive impairment associated with neurodegenerative disorders. |  Travere Therapeutics Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases. | ||
Founding Date | Founding Date 2014 | Founding Date 1990 | Founding Date 2011 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Philadelphia, US HQ | Locations Tokyo, JP HQ Dublin, IE Cambridge, GB London, GB | Locations San Diego, US HQ Dublin, IE |
Employees | Employees 1 | Employees 387 | Employees 46293% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 697 m | Valuation ($) 1.4 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥29.6b (FY, 2025) | Revenue (est.) $490.7m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ¥7.3b (FY, 2025) | Cost of goods $10.3m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit ¥24b (FY, 2025) | Gross profit $480.4m (FY, 2025) |
Net income | Net income N/A | Net income (¥12.5b) (FY, 2025) | Net income ($25.5m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 65m | Total funding raised $ 25m |
For sources of this data, please see the company profile
View Company Profiles
Sosei Heptares
HQ
Tokyo, JP
Employees
387
Sosei Heptares is a biopharmaceutical company that specializes in drug development.
View companyTravere Therapeutics
HQ
San Diego, US
Employees
462
Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.
View company